The Valley Desk

NCT00002208 · Interventional trial

A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

Overall registry status Completed

Phase 3

Conditions HIV Infections

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov